{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:04:10Z","timestamp":1789268650713,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ygyno.2023.06.019","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:35:26Z","timestamp":1689035726000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients"],"prefix":"10.1016","volume":"176","author":[{"given":"Pia","family":"Espa\u00f1ol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Luna-Guibourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"G\u00e1mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Llurba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Corchero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Virtudes","family":"C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2023.06.019_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.019_bb0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990\u20132019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"10333","key":"10.1016\/j.ygyno.2023.06.019_bb0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0020","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.019_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00428-020-03007-z","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"478","author":"Concin","year":"2021","journal-title":"Virchows Arch."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.019_bb0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(19)30020-8","article-title":"Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial","volume":"20","author":"Makker","year":"2019","journal-title":"Lancet Oncol."},{"issue":"20","key":"10.1016\/j.ygyno.2023.06.019_bb0035","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1158\/0008-5472.CAN-21-3077","article-title":"Catecholamines Mediate Psychologic Stress\u2013Induced Cancer Progression","volume":"81","author":"Bernab\u00e9","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.019_bb0040","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-20-2793","article-title":"Cancer-associated neurogenesis and nerve-cancer cross-talk","volume":"81","author":"Silverman","year":"2021","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.ygyno.2023.06.019_bb0045","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.3390\/ijms21217958","article-title":"Neurobiology of cancer: the role of \u03b2-adrenergic receptor signaling in various tumor environments","volume":"21","author":"Mravec","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.ygyno.2023.06.019_bb0050","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1242\/jcs.194803","article-title":"Cancer cells become less deformable and more invasive with activation of \u03b2-adrenergic signaling","volume":"129","author":"Kim","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ygyno.2023.06.019_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fimmu.2018.00164","article-title":"Adrenergic signaling: a targetable checkpoint limiting development of the antitumor immune response","volume":"9","author":"Qiao","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/endo-126-1-565","article-title":"Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase","volume":"126","author":"Marchetti","year":"1990","journal-title":"Endocrinology."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.019_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-011-1371-z","article-title":"Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study","volume":"130","author":"Powe","year":"2011","journal-title":"Breast Cancer Res. Tr."},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.019_bb0070","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.7150\/jca.27780","article-title":"The prospective value of dopamine receptors on bio-behavior of tumor","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"issue":"20","key":"10.1016\/j.ygyno.2023.06.019_bb0075","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1158\/0008-5472.CAN-21-1043","article-title":"Psychologic stress drives progression of malignant tumors via DRD2\/HIF1\u03b1 signaling","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ygyno.2023.06.019_bb0080","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-07-1778","article-title":"Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models","volume":"14","author":"Sarkar","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.019_bb0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/87895","article-title":"The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor","volume":"7","author":"Basu","year":"2001","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.019_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/carcin\/bgac045","article-title":"Understanding the role of dopamine in cancer: past, present and future","volume":"43","author":"Grant","year":"2022","journal-title":"Carcinogenesis."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0095","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12935-021-02298-9","article-title":"Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.019_bb0100","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/cancers12113232","article-title":"Dopamine D1 receptor in Cancer","volume":"12","author":"Sobczuk","year":"2020","journal-title":"Cancers."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0105","doi-asserted-by":"crossref","first-page":"45686","DOI":"10.1038\/srep45686","article-title":"Inhibitory effects of dopamine receptor D1 agonist on mammary tumor and bone metastasis","volume":"7","author":"Minami","year":"2017","journal-title":"Sci. Report."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0110","first-page":"61","article-title":"Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer","volume":"40","author":"Pierce","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. Cr."},{"issue":"20","key":"10.1016\/j.ygyno.2023.06.019_bb0115","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"Association WM","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.019_bb0120","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00726-017-2408-3","article-title":"Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice","volume":"49","author":"Stojanovic","year":"2017","journal-title":"Amino Acids"},{"issue":"16","key":"10.1016\/j.ygyno.2023.06.019_bb0125","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2174\/1568026619666190712210903","article-title":"Advances in dopamine D1 receptor ligands for Neurotherapeutics","volume":"19","author":"Felsing","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.019_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060021","article-title":"Targeting of beta adrenergic receptors results in therapeutic efficacy against models of Hemangioendothelioma and Angiosarcoma","volume":"8","author":"Stiles","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.019_bb0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3758\/s13428-019-01246-w","article-title":"Robust statistical methods in R using the WRS2 package","volume":"52","author":"Mair","year":"2019","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.ygyno.2023.06.019_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.019_bb0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2023.06.019_bb0150","series-title":"CompuSyn Software for Drug Combinations and for General Dose Effect Analysis, and user\u2019s Guide","author":"Chou","year":"2007"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0155","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1038\/s41598-018-23321-6","article-title":"CISNE: an accurate description of dose-effect and synergism in combination therapies","volume":"8","author":"Garc\u00eda-Fuente","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.019_bb0160","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4143\/crt.2019.510","article-title":"Activation of \u03b22-adrenergic receptor promotes growth and angiogenesis in breast cancer by down-regulating PPAR\u03b3","volume":"52","author":"Zhou","year":"2020","journal-title":"Cancer Res. Treat Official J. Kor. Cancer Assoc."},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.019_bb0165","first-page":"5059","article-title":"Prognostic significance of \u03b22-adrenergic receptor expression in non-small cell lung cancer","volume":"8","author":"Yazawa","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.019_bb0170","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10147-020-01645-6","article-title":"Prognostic significance of \u03b22-adrenergic receptor expression in patients with surgically resected colorectal cancer","volume":"25","author":"Ogawa","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.019_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fonc.2014.00375","article-title":"\u03b2-adrenergic receptor signaling in prostate cancer","volume":"4","author":"Braadland","year":"2015","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.019_bb0180","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e82","article-title":"Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study","volume":"29","author":"Baek","year":"2018","journal-title":"J. Gynecol. Oncol."},{"issue":"15_suppl","key":"10.1016\/j.ygyno.2023.06.019_bb0185","doi-asserted-by":"crossref","first-page":"e16545","DOI":"10.1200\/jco.2014.32.15_suppl.e16545","article-title":"Endometrial cancer outcomes in hypertensive women treated with beta-blocker","volume":"32","author":"Roque","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.019_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259617","article-title":"VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptors on endothelial cells","volume":"135","author":"Sarkar","year":"2022","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ygyno.2023.06.019_bb0195","article-title":"Dopamine receptors in Cancer: are they valid therapeutic targets?","volume":"20","author":"Rosas-Cruz","year":"2021","journal-title":"Technol Cancer Res T."},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.019_bb0200","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-18-2572","article-title":"Dopamine receptor D5 is a modulator of tumor response to dopamine receptor D2 antagonism","volume":"25","author":"Prabhu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ygyno.2023.06.019_bb0205","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"Jnci J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2023.06.019_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejogrb.2021.08.012","article-title":"Serous endometrial intraepithelial carcinoma (SEIC): current clinical practice in the Netherlands","volume":"265","author":"Slaager","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40425-019-0599-8","article-title":"Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration","volume":"7","author":"Stein","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.019_bb0220","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11033-019-05226-3","article-title":"Endometrial cancer and its cell lines","volume":"47","author":"Skok","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.019_bb0225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/10641963.2013.789048","article-title":"Dopamine d1-like receptors suppress proliferation of vascular smooth muscle cell induced by insulin-like growth factor-1","volume":"36","author":"Kou","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.019_bb0230","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012461","article-title":"Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism","volume":"13","author":"Hartleben","year":"2021","journal-title":"Embo Mol. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.019_bb0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0656","article-title":"Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels","volume":"166","author":"Shimazu","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0240","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-020-16735-2","article-title":"A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities","volume":"11","author":"Narayan","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.019_bb0245","doi-asserted-by":"crossref","first-page":"C116","DOI":"10.1152\/ajpcell.00468.2021","article-title":"Dopamine receptor signaling regulates fibrotic activation of retinal pigmented epithelial cells","volume":"323","author":"Gao","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823003773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823003773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:51Z","timestamp":1758772971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823003773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"alternative-id":["S0090825823003773"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}